Your browser doesn't support javascript.
loading
SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
Kawasuji, Hitoshi; Morinaga, Yoshitomo; Tani, Hideki; Yoshida, Yoshihiro; Takegoshi, Yusuke; Kaneda, Makito; Murai, Yushi; Kimoto, Kou; Ueno, Akitoshi; Miyajima, Yuki; Fukui, Yasutaka; Kimura, Miyuki; Yamada, Hiroshi; Sakamaki, Ippei; Yamamoto, Yoshihiro.
Affiliation
  • Kawasuji H; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Morinaga Y; Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Tani H; Department of Virology, Toyama Institute of Health, Toyama, Japan.
  • Yoshida Y; Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Takegoshi Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Kaneda M; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Murai Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Kimoto K; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Ueno A; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Miyajima Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Fukui Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Kimura M; Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Yamada H; Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Sakamaki I; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Yamamoto Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
J Med Virol ; 94(1): 147-153, 2022 01.
Article in En | MEDLINE | ID: mdl-34411312

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viremia / RNA, Viral / Nasopharynx / Viral Load / SARS-CoV-2 / COVID-19 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: J Med Virol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viremia / RNA, Viral / Nasopharynx / Viral Load / SARS-CoV-2 / COVID-19 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: J Med Virol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States